Notable Labs, Ltd. (NTBL)
(Delayed Data from NSDQ)
$0.40 USD
0.00 (0.00%)
Updated Oct 11, 2024 03:59 PM ET
Pre-Market: $0.26 -0.14 (-35.00%) 8:42 AM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Balance Sheet
Fiscal Year End for Notable Labs, Ltd falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 12 | 21 | 53 | 30 | 37 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 4 | 1 | 2 | 1 | 1 |
Total Current Assets | 15 | 22 | 55 | 32 | 38 |
Net Property & Equipment | 0 | 7 | 7 | 7 | 7 |
Investments & Advances | 2 | 0 | 0 | 0 | 1 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 1 | 1 | 0 |
Total Assets | 20 | 30 | 65 | 42 | 49 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 2 | 6 | 9 | 6 | 8 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 1 | 1 | 0 |
Total Current Liabilities | 3 | 7 | 10 | 7 | 9 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 1 | 2 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 2 | 1 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 4 | 7 | 14 | 11 | 13 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 0 | 0 | 0 | 0 |
Capital Surplus | 97 | 317 | 309 | 253 | 236 |
Retained Earnings | -82 | -294 | -262 | -232 | -208 |
Other Equity | 0 | 0 | 3 | 10 | 8 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 15 | 22 | 51 | 31 | 36 |
Total Liabilities & Shareholder's Equity | 20 | 30 | 65 | 42 | 49 |
Total Common Equity | 15 | 22 | 51 | 31 | 36 |
Shares Outstanding | 2.20 | 1.90 | 1.90 | 1.30 | 1.00 |
Book Value Per Share | 6.87 | 11.82 | 26.62 | 23.78 | 35.84 |
Fiscal Year End for Notable Labs, Ltd falls in the month of December.
All items in Millions except Per Share data.
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 4 | 8 | 12 | 21 |
Receivables | NA | 0 | 0 | 0 | 0 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 3 | 4 | 4 | 0 |
Total Current Assets | NA | 7 | 12 | 15 | 21 |
Net Property & Equipment | NA | 0 | 0 | 0 | 0 |
Investments & Advances | NA | 2 | 2 | 2 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 11 | 16 | 20 | 21 |
Liabilities & Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 1 | 2 | 2 | 1 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 1 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 2 |
Total Current Liabilities | NA | 3 | 3 | 3 | 3 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 4 | 4 | 4 | 3 |
Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 1 | 1 | 1 | 0 |
Capital Surplus | NA | 98 | 97 | 97 | 317 |
Retained Earnings | NA | -91 | -86 | -82 | -299 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 7 | 12 | 15 | 18 |
Total Liabilities & Shareholder's Equity | NA | 11 | 16 | 20 | 21 |
Total Common Equity | 0 | 7 | 12 | 15 | 18 |
Shares Outstanding | 9.60 | 9.00 | 9.00 | 2.20 | 2.20 |
Book Value Per Share | 0.00 | 0.80 | 1.28 | 6.87 | 8.34 |